Compared to Estimates, HealthEquity (HQY) Q2 Earnings: A Look at Key Metrics

HealthEquity (HQY) reported $325.84 million in revenue for the quarter ended July 2025, representing a year-over-year increase of 8.6%. EPS of $1.08 for the same period compares to $0.86 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $318.81 million, representing a surprise of +2.2%. The company delivered an EPS surprise of +17.39%, with the consensus EPS estimate being $0.92.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how HealthEquity performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Total HSA Assets: $33.14 billion compared to the $32.48 billion average estimate based on three analysts.Total HSA investments: $16.1 billion versus $14.78 billion estimated by three analysts on average.CDBs Accounts: 7.15 million versus the three-analyst average estimate of 6.88 million.Total Accounts: 17.14 million versus the three-analyst average estimate of 16.97 million.Total HSA cash: $17.04 billion compared to the $17.7 billion average estimate based on three analysts.HSAs Accounts: 9.99 million versus 10.1 million estimated by three analysts on average.Revenue- Service: $117.87 million versus $116.04 million estimated by four analysts on average. Compared to the year-ago quarter, this number represents a +1% change.Revenue- Custodial: $159.88 million versus the four-analyst average estimate of $155.15 million. The reported number represents a year-over-year change of +15.3%.Revenue- Interchange: $48.09 million versus the four-analyst average estimate of $46.74 million. The reported number represents a year-over-year change of +8%.View all Key Company Metrics for HealthEquity here>>>Shares of HealthEquity have returned -2% over the past month versus the Zacks S&P 500 composite's +3.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the favorite stock to gain +100% or more in the months ahead. They includeStock #1: A Disruptive Force with Notable Growth and ResilienceStock #2: Bullish Signs Signaling to Buy the DipStock #3: One of the Most Compelling Investments in the MarketStock #4: Leader In a Red-Hot Industry Poised for GrowthStock #5: Modern Omni-Channel Platform Coiled to SpringMost of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor. While not all picks can be winners, previous recommendations have soared +171%, +209% and +232%.Download Atomic Opportunity: Nuclear Energy's Comeback free today.Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report HealthEquity, Inc. (HQY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks